Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
16,024,777
-
Share change
-
+15,287,809
-
Total reported value
-
$144,383,000
-
Price per share
-
$9.01
-
Number of holders
-
16
-
Value change
-
+$137,048,999
-
Number of buys
-
16
-
Number of sells
-
1
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q3 2022
As of 30 Sep 2022,
PROKIDNEY CORP. - Ordinary Shares (PROK) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,024,777 shares.
The largest 10 holders included
MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, Bleichroeder LP, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, CREDIT SUISSE AG/, MOORE CAPITAL MANAGEMENT, LP, NORTHERN TRUST CORP, and Verition Fund Management LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.